Alto Neuroscience Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

819.72M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	210.00K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Arvinas	262.60M
Gyre Therapeutics	116.59M
MeiraGTx Holdings	81.39M
Kura Oncology	67.48M
Lexicon Pharmaceuticals	49.80M

Revenue Rankings

ANRO News

11 days ago - Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements - Business Wire
4 weeks ago - Alto Neuroscience Announces $120 Million Private Placement Financing - Business Wire
4 weeks ago - Alto Neuroscience Reports Full Year 2025 Financial Results and Recent Business Highlights - Business Wire
4 weeks ago - Alto Neuroscience Announces Participation at the Stifel 2026 Virtual CNS Forum - Business Wire
7 weeks ago - Alto Neuroscience Announces Participation in Upcoming Investor Conferences - Business Wire
2 months ago - Alto Neuroscience Announces Completion of Enrollment in Phase 2 Proof-of-Concept Study of ALTO-101 in Cognitive Impairment Associated with Schizophrenia - Business Wire
2 months ago - Alto Neuroscience Highlights Invited Review in American Journal of Psychiatry Establishing Neuroplasticity as a Core Driver of Psychiatric Disease and Treatment - Business Wire
3 months ago - Alto Neuroscience Strengthens Intellectual Property Portfolio with Issuance of New Method-of-Treatment Patent for ALTO-207 in Depression - Business Wire

More News